Skip to main content
ADHERIS HEALTH LIMITED logo

ADHERIS HEALTH LIMITED — Investor Relations & Filings

Ticker · AHE ISIN · AU0000437493 ASX Professional, scientific and technical activities
Open in API
Filings indexed 947 across all filing types
Latest filing 2026-05-18 Director's Dealing
Country AU Australia
Listing ASX AHE

About ADHERIS HEALTH LIMITED

https://www.medadvisorsolutions.com

Adheris Health Limited specializes in patient medication adherence and engagement solutions, operating as a provider of data-driven health interventions. The company utilizes an extensive pharmacy network to deliver personalized patient education, refill reminders, and behavioral support programs aimed at improving medication persistence and health outcomes. By leveraging advanced analytics and integrated pharmacy technology, it offers pharmaceutical brands targeted communication channels to engage patients at the point of care. Core services include the development of clinical trial recruitment strategies and chronic disease management support through tailored messaging. The company focuses on optimizing therapeutic results by bridging communication gaps between healthcare providers, pharmacies, and patients, ensuring consistent medication usage through evidence-based engagement tools.

Recent filings

Filing Released Lang Actions
Appendix 3Y - John Ciccio 2 pages 381.9KB
Director's Dealing Classification · 95% confidence The document is an ASX Appendix 3Y “Change of Director’s Interest Notice” detailing a director’s acquisition of shares and options, clearly reporting insider transactions under listing rule 3.19A.2. This matches the Director’s Dealing category.
2026-05-18 English
Appendix 3Y - John Ciccio 2 pages 342.2KB
Director's Dealing Classification · 95% confidence The document is an ASX Appendix 3Y ‘Change of Director’s Interest Notice’ detailing a director’s personal share transactions (number acquired, disposed, values, class of securities, etc.). This aligns exactly with the Director’s Dealing category under ASX listing rules. It is not an announcement of a report or certification, but the actual notice of insider trading activity by a director.
2026-05-11 English
Q3 FY26 Results Presentation 11 pages 847.2KB
Investor Presentation Classification · 95% confidence The document is titled 'Q3 FY26 Results Presentation' and dated 29 April 2026. It contains detailed financial results for the third quarter of fiscal year 2026, including revenue, gross profit, gross margin, and cash flow summaries. It also discusses operational updates, technology platform upgrades, short-term priorities, and an investment case. The content is structured as a presentation with slides and speaker notes, typical of an investor presentation. The document length is 8806 characters, which is sufficient to contain substantive financial data and analysis, not just a brief announcement. There is no indication that this is a full annual report or an interim report with full financial statements, but rather a quarterly results presentation focusing on financial highlights, strategy, and outlook. Therefore, the most appropriate classification is 'Investor Presentation' (IP).
2026-04-28 English
3Q FY26 Quarterly Activity Report and Appendix 4C 9 pages 391.3KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Adheris Health Q3 FY26 Report' and includes a 'Quarterly Activities Report and Appendix 4C' for the three months ended 31 March 2026. It contains detailed financial data such as revenue, gross profit, cash flow statements, and operational highlights for the quarter. The presence of Appendix 4C, which is a quarterly cash flow report required by the ASX Listing Rules, confirms this is a quarterly financial report. The document is approximately 15,000 characters long and contains substantive financial data and analysis for a period shorter than a full fiscal year. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q3 2026
2026-04-27 English
Adheris Health 3Q FY26 Results Webinar Invitation 2 pages 74.9KB
Report Publication Announcement Classification · 85% confidence The document is an ASX release titled “3Q FY26 Results Webinar Invitation” that announces the upcoming release date of the quarter’s results and invites investors to a webinar. It does not present financial results or detailed slides—it simply states when the report will be published and how to access the briefing. This fits the “Report Publication Announcement” category (RPA).
2026-04-22 English
Updated Securities Trading Policy 14 pages 409.7KB
Governance Information Classification · 92% confidence The document is an ASX release providing the full updated Securities Trading Policy – an internal governance rule regarding insider trading, closed periods and notification obligations. This is not a brief announcement or a financial report but a detailed policy on governance practices. Therefore it falls under Governance Information (CGR).
2026-04-21 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.